A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects

NCT04796831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Quizartinib dihydrochloride
DRUG: 14C-Quizartinib solution for infusion

Sponsor

Daiichi Sankyo

Collaborators

[object Object]